<DOC>
	<DOCNO>NCT01110746</DOCNO>
	<brief_summary>The purpose study evaluate Effect Post-prandial Glycemia Safety , Tolerability Viaject 7 vs. Lispro Insulin SC Insulin Pump Therapy .</brief_summary>
	<brief_title>To Evaluate Effect Post-prandial Glycemia Safety , Tolerability Viaject 7 vs. Lispro Insulin During Subcutaneous Insulin Pump Therapy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>1 . Males female diagnose type 1 diabetes mellitus least 6 month 2 . Current usage subcutaneous insulin pump treatment one follow pump : Medtronic Paradigm速 Animas速 OmniPod速 ACCUCHEK Spirit速 3 . Age 1875 year 4 . HbA1c 6.0 9.0 % screen visit . 5 . Willingness attend 9 clinic visit . 1 . Pregnancy Lactation 2 . Renal insufficiency ( serum creatinine 2.0 mg/dL great ) . 3 . Anemia 4 . Congestive heart failure . 5 . Visual impairment prevent read glucose meter value ability use insulin pump continuous glucose monitoring device . 6 . Active coronary artery disease heart procedure within past 4 month . 7 . Active foot ulceration . 8 . Severe peripheral arterial disease . 9 . Stroke within past 6 month . 10 . Active alcohol abuse , substance abuse , severe mental illness . 11 . Active cancer , except basal cell squamous cell skin cancer . 12 . Major surgical operation within 30 day prior screen . 13 . Seizure disorder ( epilepsy ) . 14 . Any concurrent illness , diabetes , control stable therapeutic regimen . 15 . Currently use corticosteroid . 16 . History major noncompliance . 17 . Use investigational drug within 30 day prior screen . 18 . Bleeding disorder , treatment warfarin , low platelet count . 19 . Any insulin allergy 20 . Current complaint major infusion site problem commercially available insulin preparation , frequent occurrence infection , mark swell mark erythema . 21 . History gastroparesis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>